Abstract
The UK government’s five year antimicrobial resistance national action plan will need to tackle the lack of progress and a rapidly declining workforce
Antimicrobial resistance (AMR) is one of the most pressing challenges of our time. Resistance to commonly used antimicrobial medicines is already disrupting medicine and adversely affecting patient treatment.1 Efforts have been made internationally to reduce overuse of antimicrobials and to preserve them for future generations, but there is still much to be done. The UK will be at the forefront of these efforts nationally and internationally with its national action plan (NAP)2 that sets out five years of action to support a 20 year vision to tackle antimicrobial resistance collaboratively across borders. But the plan overlooks important aspects of antimicrobial resistance and does not consider the declining AMR workforce.
Antimicrobial resistance (AMR) is one of the most pressing challenges of our time. Resistance to commonly used antimicrobial medicines is already disrupting medicine and adversely affecting patient treatment.1 Efforts have been made internationally to reduce overuse of antimicrobials and to preserve them for future generations, but there is still much to be done. The UK will be at the forefront of these efforts nationally and internationally with its national action plan (NAP)2 that sets out five years of action to support a 20 year vision to tackle antimicrobial resistance collaboratively across borders. But the plan overlooks important aspects of antimicrobial resistance and does not consider the declining AMR workforce.
Original language | English |
---|---|
Article number | q2104 |
Pages (from-to) | q2104 |
Journal | British Medical Journal |
Volume | 386 |
DOIs |
|
Publication status | Published - 26 Sept 2024 |